Results 221 to 230 of about 56,454 (256)
Some of the next articles are maybe not open access.

Gastrointestinal Stromal Tumors and Neuroendocrine Tumors

Seminars in Oncology Nursing, 2009
Patients with rare gastrointestinal (GI) malignancies can exhibit unique objective and subjective manifestations. This article is a primer for the fundamental understanding of some of these diseases, namely gastrointestinal stromal tumors (GIST) and gastroenteropancreatic neuroendocrine tumors (NET) and therapeutic strategies.Epidemiologic data ...
Carolyn, Grande, Daniel G, Haller
openaire   +2 more sources

GASTROINTESTINAL STROMAL TUMOR

2010
Gastrointestinal stromal tumor, i.e., GIST is by far the most common mesenchymal tumor of the gastrointestinal tract. GIST has received special clinical attention, because it is one of the first solid tumors treated with tyrosine kinase inhibitors as targeted oncological therapy.
openaire   +2 more sources

Gastrointestinal stromal tumor (GIST)

Current Treatment Options in Gastroenterology, 2006
Gastrointestinal stromal tumors (GISTs), the most common nonepithelial neoplasms of the gastrointestinal (GI) tract, occur most commonly in the stomach. These neoplasms were previously classified as smooth muscle tumors, but it has become apparent that they represent distinct clinicopathologic entities.
Mitchell L, Schubert, Robert, Moghimi
openaire   +2 more sources

Gastrointestinal stromal tumor of the prostate

Urology, 2005
We present a unique case of an atypical prostate tumor in a 49-year-old man with acute urinary retention. Digital rectal examination revealed a large prostate with a parenchymal mass on the left side. Radiologic imaging showed a 14.2 x 9.6 x 14.0-cm prostatic mass and multiple liver metastases.
Frank, Van der Aa   +7 more
openaire   +2 more sources

Management of Gastrointestinal Stromal Tumors

Surgical Clinics of North America, 2008
A gastrointestinal stromal tumor (GIST) is a rare mesenchymal malignancy of the gastrointestinal (GI) tract. Malignant GISTs were first defined as a separate entity from a collection of nonepithelial malignancies of the GI tract in the 1980s and 1990s based on pathologic and clinical behavior. The discovery of activating KIT mutations as a near-uniform
Matthew T, Hueman, Richard D, Schulick
openaire   +2 more sources

Pediatric Gastrointestinal Stromal Tumors

Hematology/Oncology Clinics of North America, 2009
Gastrointestinal stromal tumors (GISTs) rarely occur in pediatric patients, but increased recognition of adult GIST has led to better awareness of the existence of this entity in the pediatric population. GIST occurring in pediatric patients has a unique biology and clinical behavior and warrants discussion as an independent entity.
Alberto S, Pappo, Katherine A, Janeway
openaire   +2 more sources

Management of Gastrointestinal Stromal Tumors

Surgical Clinics of North America, 2017
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasm of the gastrointestinal tract. The stomach is the most common site of origin. Management of GISTs changed after the introduction of molecularly targeted therapies. Although the only potentially curative treatment of resectable primary GISTs is surgery, recurrence is common.
Emily Z, Keung, Chandrajit P, Raut
openaire   +2 more sources

Management of Gastrointestinal Stromal Tumors

Surgical Clinics of North America, 2016
Gastrointestinal stromal tumors had the reputation for poor outcomes because of their lack of response to nonsurgical interventions. The discovery of gain-of-function mutations involving receptor tyrosine kinase growth factor receptors altered the biological understanding and management.
openaire   +2 more sources

Gastrointestinal stromal tumors and leiomyosarcomas

Journal of Surgical Oncology, 2008
AbstractOnly recently has gastrointestinal stromal tumor (GIST) been recognized as the most frequent GI mesenchymal neoplasm. Prior to the use of KIT staining, most GI stromal tumors were identified as leiomyosarcoma (LMS). For primary GIST, surgery remains the principal treatment and adjuvant imatinib may improve outcomes.
Steven C, Katz, Ronald P, DeMatteo
openaire   +2 more sources

Pediatric Gastrointestinal Stromal Tumor

Journal of Pediatric Gastroenterology and Nutrition, 2023
Łukasz Dembiński   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy